Associated partners

Timothy STEINER, World Headache Alliance, Charing Cross Campus, St Dunstan's Road, London W6 8RP, UNITED KINGDOM;

Colette ANDREE, project director, Centre de Recherche Publique /Dep. Pharm. Sciences University Basle, Oberwilerstr 48, CH-4103 Bottmingen, SUISSE;

Miguel LAINEZ, Fundacion para la Investigacion Biomedica, la Docencia y la Cooperacion Internacional, Camí de l'Almazara Nº 11 - 3ª planta edificio anexo, ES-03203 Elche (Alicante), SPAIN;

Michel LANTERI-MINET, CHU-Hôpital Pasteur, Département d'Evaluation et de traitement de la douleur, 30 avenue de la Voie Romaine, FR-06002 Nice, FRANCE;

Peter VRIEZEN, Nederlandse Vereniging van Hoofdpijnpatienten, Postbus 2185, NL-3800 CD Amersfoort, THE NETHERLANDS;

Christian LAMPL, Koventhospital Barmherzige Brüder, Seilerstätte 2, AT-4021 Linz, AUSTRIA;

Lars Jacob STOVNER, St Olavs Hospital, Olav Kyrres gate 17, NO-7006 Trondheim, NORWAY;

Zaza Katsarava, University of Essen, Hufelandstrasse 55, DE-45122 Essen, GERMANY;

Cristina TASSORELLI, Centro Italiano di Ricerche Neurologiche Applicate (CIRNA), 6, Via Oberdan, IT-27100 Pavia, ITALY;

Grazia SANCES, Centro Italiano di Ricerche Neurologiche Applicate (CIRNA), 3, Via Bonetteâ, IT-27100 Pavia, ITALY;

Anne MACGREGOR, The City of London Migraine Clinic, 22 Charterhouse Square, EC1M 6DX London, UNITED KINGDOM;

Daiva RASTENYTE, Kaunas University of Medicine, A. Mickeviciaus 9, LT-44307 Kaunas, LITHUANIA;

Migraine Association of Ireland, Senior House, All Hallows College, Gracepark Road, Drumcondra, Dublin 9, IRELAND;

Elena RUIZ DE LA TORRE, Asociacion Española de Pacientes con Cefalea, Calle del Mar 58-8, ES-46003 Valencia, SPAIN (supported by Miguel LAINEZ);

Migraine Action Association UK, 6 Oakley Hay Lodge Business Park, Great Folds Road, Great Oakley, Northants, NN18 9AS, UNITED KINGDOM;

European Headache Alliance, 1A rue Thomas Edison, L-1445 Strassen, LUXEMBOURG;

Gérard MICK, Réseau Voironnais de la Douleur, Centre Hospitalier, BP 208, FR-38506 Voiron, FRANCE.